ARCHIVED - Health Canada - Supplementary Tables

Federal Tobacco Control Strategy

1. Name of Horizontal Initiative: Federal Tobacco Control Strategy (FTCS)

2. Name of lead department(s): Health Canada

3. Lead department program activity: Substance Use and Abuse

4. Start date of the Horizontal Initiative: April 2007

5. End date of the Horizontal Initiative: Funding for the initiative is ongoing but the current policy authority ends March 31, 2012. Further information is not available at this time.

6. Total federal funding allocation (start to end date): $419.6M - Funding for the initiative is ongoing but the current policy authority ends March 31, 2012. Further information is not available at this time.

7. Description of the Horizontal Initiative (including funding agreement): The FTCS establishes a framework for a comprehensive, fully-integrated, and multi-faceted approach to tobacco control. It is driven by the longstanding commitment of the Government of Canada to reduce the serious and adverse health effects of tobacco for Canadians. It focuses on four mutually reinforcing components: prevention, cessation, protection, and product regulation.

8. Shared outcome(s): The long-term outcome of the FTCS is to reduce tobacco-related disease and death in Canada.

9. Governance structure(s): N/A

10. Planning Highlights: Among ongoing activities, the Department will continue the enforcement of provisions of the Cracking Down on Tobacco Marketing Aimed at Youth Act (2009) and will continue to implement the new labelling requirements for cigarettes and little cigars, including larger health warning messages, and a pan-Canadian quitline number and a web address to encourage Canadians to quit smoking.

11. Federal Partner(s):

Health Canada (HC)

Federal Partner Program Spending ($ millions)

Federal Partner Program Activity (PA)	Names of Programs for Federal Partners	Total Allocation (from Start to End Date)	Planned Spending for 2012-13
Substance Use and Abuse	FTCS	Total from 2007-08 to 2012-13 322.2M	52.5M
Total		322.2M	52.5M

Public Safety Canada (PSC)

Federal Partner Program Spending ($ millions)

Federal Partner Program Activity (PA)	Names of Programs for Federal Partners	Total Allocation (from Start to End Date)	Planned Spending for 2012-13
Law Enforcement Strategies	FTCS	Total from 2007-08 to 2012-13 3.7M	0.6M
Total		3.7M	0.6M

Royal Canadian Mounted Police (RCMP)

Federal Partner Program Spending ($ millions)

Federal Partner Program Activity (PA)	Names of Programs for Federal Partners	Total Allocation (from Start to End Date)	Planned Spending for 2012-13
RCMP	FTCS	Total from 2007-08 to 2012-13
Police Operations		4.9M	0.8M
Canadian Law Enforcement Services		5.4M	0.9M
Total		10.3M	1.7M

Office of the Director of Public Prosecutions (ODPP)

Federal Partner Program Spending ($ millions)

Federal Partner Program Activity (PA)	Names of Programs for Federal Partners	Total Allocation (from Start to End Date)	Planned Spending for 2012-13
ODPP	FTCS	Total from 2007-08 to 2012-13 11.9M	2.0M
Total		11.9M	2.0M

Canada Revenue Agency (CRA)

Federal Partner Program Spending ($ millions)

Federal Partner Program Activity (PA)	Names of Programs for Federal Partners	Total Allocation (from Start to End Date)	Planned Spending for 2012-13
Taxpayers and Business Assitance	FTCS	Total from 2007-08 to 2012-13 5.3M	0.9M
Total		5.3M	0.9M

Canada Border Services Agency (CBSA)

Federal Partner Program Spending ($ millions)

Federal Partner Program Activity (PA)	Names of Programs for Federal Partners	Total Allocation (from Start to End Date)	Planned Spending for 2012-13
CBSA - Risk Assessment	FTCS	Total from 2007-08 to 2012-13
CBSA - Admissibility Determination	FTCS		0.2M
Total		67.7*	2.6M

*Approximately $2M was deducted from the total allocation to date as well as the ongoing total since 2011-12, as a result of Strategic Review reductions.  Also, of the $7.9M in yearly funding received by CBSA, $4.3M is related to compensation for revenue lost (loss of Duty Free Licensing) and is allocated to other Agency activities.

Expected results by program:

Federal Partners - Total Program Spending ($ millions)

Total Allocation For All Federal Partners (from Start to End Date)	Total Planned Spending for All Federal Partners for 2012-13
Notes: All allocation figures include EBP and PWGSC Accommodations costs. HC total allocation figures are final budget allocations, which factors in all permanent reductions by the end of each fiscal year.
Total from 2007-08 to 2012-13	60.3M

12. Results to be achieved by non-federal partners (if applicable): N/A

13. Contact information:

Cathy A. Sabiston
Director General
Controlled Substances and Tobacco Directorate
Health Canada
Telephone: 613-941-1977

Defence of Canada Against Third-Party Claims in Tobacco Litigation

1. Name of Horizontal Initiative: Defence of Canada Against Third-Party Claims in Tobacco Litigation

2. Name of lead department(s): Health Canada

3. Lead department program activity: Substance Use and Abuse

4. Start date of the Horizontal Initiative: 2010-2013

5. End date of the Horizontal Initiative: March 31, 2013

6. Total federal funding allocation (start to end date): $45.738 million

7. Description of the Horizontal Initiative (including funding agreement): The purpose of this horizontal initiative is to defend Canada against third party claims in tobacco litigation. The source of funding for this initiative is:

• $34,878,000 over three fiscal years from the fiscal framework in Budget 2010 ($29,742,000 for Health Canada and $5,136,000 for Agriculture and Agri-Food Canada);
• Up to $9,000,000 from Health Canada's existing reference levels ($3,000,000 in 2010-11, $3,000,000 in 2011-12, and $3,000,000 in 2012-13); and
• Up to $1,860,000 from Agriculture and Agri-Food Canada's existing reference levels ($1,100,000 in 2010-11, $380,000 in 2011-12, and $380,000 in 2012-13).

8. Shared outcome(s):

• To defend Canada against third party claims in tobacco litigation; and,
• To meet all our legal obligations in a timely manner.

9. Governance structure(s): The major stakeholders are Health Canada, Agriculture and Agri-Food Canada and Justice Canada. While acting within their respective mandates, the defence effort is coordinated by the Interdepartmental Assistant Deputy Minister Steering Committee on Tobacco Litigation. The committee is co-chaired by the three departments and ensures the management of issues and finances.

10. Planning Highlights: In light of the favorable decision of the Supreme Court of Canada in July 2011, and with the guidance and support from Justice Canada, Health Canada and Agriculture Canada will continue to defend Canada against third-party claims in all tobacco litigation as required.

11. Federal Partner(s):

Health Canada (HC)

Federal Partner Program Spending ($ millions)

Federal Partner Program Activity (PA)	Names of Programs for Federal Partners	Total Allocation (from Start to End Date)	Planned Spending for 2012-13
PA 2.5 Substance Use and Abuse	Defence of Canada Against Third-Party Claims in Tobacco Litigation	29.742 from new funding 9.0 (up to) from existing reference levels	8.641 from new funding 3.0 (up to) from existing reference levels
Total		38.742	11.641

Expected results by program: Canada is defended against third-party claims in tobacco litigation and has met its legal obligations.

Agriculture and Agri-Food Canada (AAFC)

Federal Partner Program Spending ($ millions)

Federal Partner Program Activity (PA)	Names of Programs for Federal Partners	Total Allocation (from Start to End Date)	Planned Spending for 2012-13
Internal Services	Defence of Canada Against Third-Party Claims in Tobacco Litigation	5.136 from new funding 1.860 (up to) from existing reference levels	1.936 from new funding 0.380 (up to) from existing reference levels
Total		6.996	2.316

Expected results by program: Canada is defended against third-party claims in tobacco litigation and has met its legal obligations.

12. Results to be achieved by non-federal partners (if applicable): N/A

13. Contact information:

Louis Proulx
A/Director
Health Canada Litigation Support Office
99 Metcalfe
Ottawa, Ontario K1A 0K9
Telephone: 613-957-3659

FCSAP to Protect Human Health From Environmental Contaminants

1. Name of Horizontal Initiative: FCSAP to Protect Human Health from Environmental Contaminants

2. Name of lead department(s): Health Canada

3. Lead department program activity: Sustainable Environmental Health

4. Start date of the Horizontal Initiative: 2008-2009

5. End date of the Horizontal Initiative: 2012-2013

6. Total federal funding allocation (start to end date): $84.6M

7. Description of the Horizontal Initiative (including funding agreement): Recent surveys show that Canadians are concerned about environmental contaminants. There is a clear need to ensure that Canadians have credible information on the impact of chemicals in the environment and the steps that they should take as a result.

The Government has already taken steps to address environmental contaminants through the Chemicals Management Plan and the Clean Air Agenda, focusing on substances which have known potential for harming human health and the environment. Both industry and stakeholders have been supportive of these initiatives but continue to insist that decisions be made based on scientific evidence. This requires mechanisms such as monitoring, surveillance and research to ensure that the effectiveness of interventions to address known potential risks can be assessed and that emerging risks can be detected.

The FCSAP to Protect Human Health from Environmental Contaminants is designed to further protect the health of Canadians from environmental contaminants while increasing the knowledge-base on contaminant levels and potential impacts on health, in particular:

• to foster awareness and provide information for Canadians to take action;
• to identify and monitor trends in exposures to contaminants and potentials
• association with health problems such as asthma, congenital anomalies and developmental disorders; and
• to better understand the association between contaminants and illness.

$13.1M has been allocated to Health Canada from 2008-2009 to 2012-2013 to develop an Environmental Health Guide for Canadians, as well as tailored guides for First Nations and Inuit communities. The objective of the guide is to help make Canadians aware of the risks that harmful environmental contaminants may pose to their health along with direct actions that they can take to reduce these risks and improve their health. The Guide, Hazardcheck, was published March 1, 2010. The First Nations and Inuit Guides, Your Health at Home, were published on May 7, 2010 and April 11, 2011 respectively.

$54.5M has been allocated to Statistics Canada from 2008-2009 to 2012-2013 towards conducting the Canadian Health Measures Survey (CHMS) and $5.6M from 2008-2009 to 2012-2013 for Health Canada to conduct the First Nations Biomonitoring Initiative (FNBI). The CHMS is used to collect information from Canadians about their general health and lifestyles and includes collection of blood and urine specimens to be tested for environmental contaminants among other things. The CHMS will not provide data on First Nations on-reserve or Inuit communities. Data for First Nations' peoples on reserve will be captured under the First Nations Biomonitoring Initiative.

$5.9M has been allocation to the Public Health Agency of Canada from 2008-2009 to 2012-2013 to enhance surveillance of congenital anomalies.

$5.5M has been allocation to the Public Health Agency of Canada from 2008-2009 to 2012-2013 to conduct surveillance of developmental disorders.

8. Shared outcome(s): Reduce health risks to Canadians (particularly vulnerable populations) from environmental contaminants.

9. Governance structure(s): All FCSAP initiatives take advantage of governance and management structures already established for ongoing government programs such as: the Canadian Population Health Statistics Program, the Chemicals Management Plan, the Healthy Living and Chronic Disease initiative of the Public Health Agency of Canada, as well as components of existing national surveillance systems developed by the Public Health Agency of Canada in partnership with stakeholders.

Each program within Health Canada, the Public Health Agency of Canada and Statistics Canada will be fully responsible for the management of initiatives they are leading within the FCSAP. Consultations and stakeholder involvement will be governed through consultative structures and interdepartmental committees already established.

A tripartite governance structure between Health Canada, the Public Health Agency of Canada and Statistics Canada will be used to oversee the implementation of the Canadian Health Measures Survey (CHMS). The CHMS will use the existing Canadian Population Health Statistics Program as a governance structure, which includes senior officials from all three federal organizations.

10. Planning Highlights:

Environmental Health Guide for Canadians

The Environmental Health Guide for Canadians has been developed with partners across the Health Portfolio and with the Canadian Mortgage and Housing Corporation to raise awareness among Canadians about environmental hazards and to inform them of what they can do to reduce their exposure to these risks such ascarbon monoxide, mould, radon, second-hand smoke, and lead.

A public awareness and education campaign was launched in March 2010 to promote the new Environmental Health guide and to raise awareness of the link between health and the environment. To complement on-line tactics (blogger outreach, twitter and Facebook posts), public engagement events were held at 121 retail locations over 2 consecutive weekends in October and November 2011, thereby educating Canadians on the environmental issues that could impact their health.

Activities for 2012-13 are currently being planned to build on the momentum generated by the campaign. This will include an environmental health product focusing on seniors aged 65+, an exploration of partnerships with various non-Governmental and private sector collaborators, and ongoing public relations and outreach activities. Program evaluation will also be undertaken.

The First Nations Environmental Health Guide-Your Health at Home, What you can do is available on the Health Canada web site and has been mailed out to First Nations communities across Canada. Also available on the Health Canada web site are the First Nations and Inuit youth guides and activity booklets, and the Inuit Home Guide. The First Nations Spring/Summer outdoor guide will be posted on the Health Canada Website by the beginning of the 2012-13 fiscal year. These materials will also be distributed to communities across Canada.

In addition, the First Nations Fall/Winter Guide and Inuit seasonal guides were developed in 2011/12 and planned distribution will take place during the 2012/13 fiscal year. These guides will be supported through targeted public awareness and education activities, including radio advertising, online advertising (Facebook, Google and YouTube), print public service announcements, a youth art contest, a pilot project with the Aboriginal People's Television Network, activity booklets for teens and kids, and social media (Facebook and Twitter).

First Nations Biomonitoring Initiative

The First Nations Biomonitoring Initiative (FNBI) is a partnership between Health Canada and the Assembly of First Nations. It is a health survey which seeks to establish baseline information on human exposure to environmental contaminants for First Nations' people on reserve. The survey contains a household questionnaire, direct physical measurements, and biospecimen collection (blood and urine). The environmental chemicals that will be measured include: metals, PCBs, pesticides, phthalates, perfluorinated compounds, etc. This Initiative was developed to complement the Canadian Health Measures Survey (CHMS), which excludes First Nations' people on reserve. 

In 2011-12, laboratory results from the pilot project were received. Based on the operational and logistical findings from the pilot project, the full-scale health survey was conducted in 13 randomly selected First Nation communities (42 participants per community) across Canada. Over 500 First Nation peoples participated to yield a 92% success rate. Laboratory analysis from the full-scale survey will be available by the beginning of the 2012-13 fiscal year.

The 2012-13 fiscal year will be the Analysis and Dissemination Phase. Analysis of the laboratory data will be carried out. Participants of the health survey will be provided with their individual results and community summary reports for each First Nation community that was part of the health survey will be developed and presented to the community. A national report will also be prepared of the aggregate findings. 

Enhanced Congenital Anomalies Surveillance

In 2012-2013 the Public Health Agency of Canada (PHAC) will continue to work with the provinces and territories on the implementation of congenital anomalies surveillance systems in the various jurisdictions. It will also continue its participation in the International Clearinghouse for Birth Defects Surveillance and Research and organize the 10th Annual Scientific Meeting of the Agency's Canadian Congenital Anomalies Surveillance Network.

Surveillance of Developmental Disorders

In 2012-2013 the Public Health Agency of Canada (PHAC) will continue to build a national surveillance system for Autism Spectrum Disorders (ASD). In 2011-12, PHAC established relationships with surveillance partners and stakeholders, put in place an expert ASD Advisory Committee to oversee the development process, and completed the preliminary research necessary to inform the selection of the most appropriate surveillance option for ASD surveillance. Options include the use of administrative datasets, sentinel surveillance, clinical databases, population based surveys and/or registries. With input from the ASD Expert Advisory Committee, PHAC will determine the most cost-effective, comprehensive, flexible and reliable surveillance option(s) for a national ASD surveillance system.

In 2012-13, the focus will be on establishing the surveillance methodology, as well as implementing pilot projects to identify indicators, case definitions, data sources, and a sampling approach. This work will be done collaboratively, with the guidance of the ASD Advisory Committee, and with experts in the field, other levels of government and other stakeholders.

Canadian Health Measures Survey (CHMS)

In 2012-13 the CHMS team will be working simultaneously on three cycles of the survey:

Cycle 3 (2012-2013): Data collection begins in Montreal QC, the first of 16 national sites. Data collection response rates will be monitored regularly to ensure adequate representation of the Canadian population by age group and sex.

Four new measures in support of environmental contaminants include passive sampling and measurement of household tap water for volatile organic compounds (VOCs) and fluoride; hearing tests to support examination of hearing loss and its association with noise exposure/noise pollution; a Fractional exhaled Nitric Oxide (FeNO) measurement that directly measures airway inflammation; and an objective test of skin pigmentation. 

Cycle 2 (2009-2011): Data processing and validation will begin in FY 2012-13, with the first data files planned for release and dissemination in the fall, 2012.

Cycle 1 (2007-2009): The first studies using stored samples from the CHMS biobank begin in 2012 according to published protocols. More than 50 studies based on CHMS data in 21 universities across Canada will continue in 2012 through the Research Data Centre Network.

11. Federal Partner(s): 

Health Canada (HC)

Federal Partner Program Spending ($ millions)

Federal Partner Program Activity (PA)	Names of Programs for Federal Partners	Total Allocation (from Start to End Date)	Planned Spending for 2012-13
PA 3.1 Sustainable Environmental Health HECSB & PACCB	Environmental Health Guide for Canadians	HECSB 3.0	HECSB 0.4
		PACCB: 6.5	PACCB: 0.2
	PA 3.1 Sub-total	9.5	0.6
PA 4.1 First Nations and Inuit Health Programming and Services FNIHB & PACCB	Environmental Health Guide for First Nations	FNIHB: 1.5	FNIHB: 0.1
		PACCB: 2.1	PACCB: 0.1
		3.6	0.2
	First Nations Biomonitoring Initiative	5.6	0.7
	PA 4.1 Sub-Total	9.3	0.9
Total		18.7	1.5

Expected results by program:

• Distribution of the Environmental Health Guides.
• Increased online discussion of the link between health and home environments.
• Tailored Guides for First Nations and Inuit Fall/Winter and Spring/Summer Outdoor activities are developed and distributed to aboriginal communities.
• Continuation of the Environmental Health marketing campaign (mainstream and First Nations components).
• Tailored environmental health product for seniors 65+ is published and distributed.
• Preparation and distribution of a national report on the findings from the First Nations Biomonitoring Initiative.
• Preparation of community reports on health survey results for that particular community.
• Reliable and usable data for First Nation communities, researchers, and government on the health status of First Nations' exposure to environmental contaminants and enable comparison between First Nations and the Canadian population.
• Participants and/or communities to take action to reduce exposure levels to chemical(s) of concern.

Statistics Canada (SC)

Federal Partner Program Spending ($ millions)

Federal Partner Program Activity (PA)	Names of Programs for Federal Partners	Total Allocation (from Start to End Date)	Planned Spending for 2012-13
PA 2 Social Statistics	Canadian Health Measures Survey	54.5	14.0
Total		54.5	14.0

Expected results by program:

• CHMS Cycle 1: All data from Cycle 1 will be in the public domain and the CHMS biobank will be available for access by researchers according to published protocols. Access to the data by users and researchers, use of the data files in the Research Data Centres, publications in journals, media and other channels will be tracked and monitored.
• CHMS Cycle 2: Data collection response rates are monitored regularly to ensure adequate representation of the Canadian population by age group and sex. Ongoing data quality control and data quality assurance activities, including observation of the data collection procedures by health experts, are performed to ensure a high data quality level.
• CHMS Cycle 3: Specifications for data collection and processing applications, operations manuals and lab and clinic manuals will be developed in collaboration with health experts, through working groups and advisory committees, and federal partners through the tripartite governance structure between Health Canada, the Public Health Agency of Canada and Statistics Canada. Pilot testing and feasibility studies will determine appropriate operational processes to ensure high response rates and quality data while ensuring adherence to planned resources.

Public Health Agency of Canada (PHAC)

Federal Partner Program Spending ($ millions)

Federal Partner Program Activity (PA)	Names of Programs for Federal Partners	Total Allocation (from Start to End Date)	Planned Spending for 2012-13
PA 1.2 Surveillance and Population Health Assessment	Enhanced Congenital Anomalies Surveillance	5.8	1.7
	Surveillance of Developmental Disorders	5.3	1.7
Total		11.1	3.4

Expected results by program:

• Enhanced Congenital Anomalies Surveillance: increased capacity in the provinces and territories for surveillance of congenital anomalies in their jurisdictions and strengthened networks across Canada for surveillance and research into prevention of congenital anomalies.
• Surveillance of Developmental Disorders: a network for surveillance of autism in Canada and increased public health scientific capacity on autism within the federal government.

12. Results to be achieved by non-federal partners (if applicable): N/A

13. Contact information:

Suzanne Leppinen
Director
Chemicals Policy Bureau
Safe Environments Directorate
Healthy Environments and Consumer Product Safety Branch
Health Canada
Telephone: 613-941-8071

Chemical Management Plan

1. Name of Horizontal Initiative: Chemicals Management Plan

2. Name of lead department(s): Health Canada (HC)/Environment Canada (EC)

3. Lead department program activity: Environmental Risks to Health (HC)/Substances and Waste Management (EC)

4. Start date of the Horizontal Initiative: 2011-2012 (second phase)

5. End date of the Horizontal Initiative: 2015-2016 (second phase)

6. Total federal funding allocation (start to end date): $516 M

7. Description of the Horizontal Initiative (including funding agreement): Originally launched in 2006, the Chemicals Management Plan (CMP) enables the Government of Canada to protect human health and the environment by addressing substances of concern in Canada. It is a science-based approach that includes:

• setting priorities and government-imposed timelines for risk assessment and risk management for chemicals of concern;
• enhancing research, monitoring and surveillance;
• increasing industry stewardship and responsibilities for substances;
• collaborating internationally on chemicals assessment and management;
• communicating to Canadians the potential risks of chemical substances;
• engaging industry to inform risk assessment and risk management action while also enhancing trust in the program.

Jointly managed by Health Canada and Environment Canada, the CMP brings all existing federal chemical programs together under a single strategy. This integrated approach allows the Government of Canada to address various routes of exposure to chronic and acute hazardous substances. It also enables use of the most appropriate management tools among a full suite of federal laws, which include the Canadian Environmental Projection Act, 1999, the Canada Consumer Product Safety Act (which replaced the Hazardous Products Act in June 2011), the Food and Drugs Act, and the Pest Control Products Act. 

Building on lessons learned in the first four years of the program, CMP priority setting was refined and, under this phase of the CMP substances will be grouped to facilitate more efficient assessments, industry participation and risk management. Integration across government programs remains critical since many remaining substances are found in consumer, health, drug and other products. 

The same core functions continue: risk assessment; risk management, compliance promotion and enforcement; research; monitoring and surveillance; stakeholder engagement and risk communications; and policy and program management.

The following program areas are involved in CMP activities:

In Health Canada

Health Products and Food Branch:

• Biologics and Genetic Therapies Directorate
• Food Directorate
• Natural Health Products Directorate
• Policy, Planning and International Affairs Directorate
• Therapeutics Products Directorate
• Veterinary Drugs Directorate

Healthy Environments and Consumer Safety Branch:

• Consumer Product Safety Directorate
• Safe Environments Directorate
• Environmental and Radiation Health Sciences Directorate

Pest Management Regulatory Agency

In Environment Canada

Environmental Stewardship Branch:

• Chemicals Sector Directorate
• Legislative and Regulatory Affairs Directorate
• Public and Resources Sectors Directorate
• Energy and Transportation Directorate
• Environmental Protection Operations Directorate

Science and Technology Branch:

• Science and Risk Assessment Directorate
• Wildlife and Landscape Sciences Directorate
• Atmospheric Science and Technology Directorate
• Water Science and Technology Directorate

Enforcement Branch

Strategic Policy Branch:

• Economic Analysis Directorate

For more information, see the Government of Canada's Chemical Substances Portal

8. Shared outcome(s):

Immediate Outcomes:

• Knowledge, information and data on substances of concern is used by HC and EC recipients to inform risk management, risk communication and stakeholder engagement, research, risk assessment, and monitoring and  surveillance activities;
• Canadians and stakeholder groups understand information on the risks and safe use of substances of concern;
• Targeted industry conforms or complies with requirements of risk management measures;
• Targeted industry takes voluntary or enforced action to protect Canadians and the environment;
• Targeted industry understands its obligations to take action to protect Canadians and the Environment.

Intermediate Outcomes:

• Canadians use information on the risks and safe use of substances of concern to avoid or minimize risks posed by these substances;
• Risks associated with harmful substances in humans, the environment, food and consumer products are prevented, minimized or eliminated.

Final Outcome:

• Reduced threats to health and the environment from harmful substances.

9. Governance structure(s): In meeting their obligations pursuant to the CMP, EC and HC deliver their responsibilities through established internal departmental governance structures. CMP governance is assured through a joint Assistant Deputy Ministers Committee (CMP ADM Committee) and an Interdepartmental Chemicals Management Executive Committee (CMEC). These Committees were established to maximize the coordination of efforts, while minimizing duplication between the two departments.

The CMP ADM Committee provides strategic direction, coordination and a challenge function for the implementation and review of results and resource utilization of the CMP. The CMEC is the management committee at the Director General level to support the development of joint Health Canada/Environment Canada strategic directions. It is also a formal body for cooperation to ensure timely and concerted actions in implementing the CMP activities in an integrated fashion. The CMEC reports to the ADM Committee, providing recommendations on program implementation, results and resource utilization.

10. 2012-213 Planning Highlights: In 2012-2013, HC and EC will continue to assess and manage the potential health and ecological risks from the remaining high priority substances from the first phase of the CMP, including completion of assessments from the Petroleum Sector Stream Approach, as well as the assessment of other substances deemed to be a priority. Screening Assessment Reports and Risk Management Strategies for high priorities will be completed and risk management measures will continue to be developed, implemented, tracked and monitored. Work with other jurisdictions bilaterally and in multinational fora to undertake regional and multilateral efforts to manage chemicals of concerns will continue.

The next phase of the CMP will see the continued assessment and management of the potential health and ecological risks associated with approximately 1,500 substances by 2015 through the substance groupings initiative, rapid screening, and other approaches. During 2012-2013, data collection activities will take place for the following groups of substances:

• Aromatic azo- and benzidine-based substances;
• Certain internationally-classified substances with potential for exposure to individuals in Canada;
• Cobalt-containing substances;
• Methylenediphenyl diisocyanates and diamines (MDI/MDA); and
• Substituted diphenylamines.

Health Canada will continue to conduct risk assessments and develop and implement risk management measures to address risks posed by harmful chemicals in foods, consumer products, cosmetics and drinking water. Highlights for 2012-13 include the publication of regulations under the Canada Consumer Product Safety Act in Canada Gazette Part II for two CMP substances - (2-chloroethyl) phosphate (TCEP) and 2-(2-methoxyethoxy) ethanol (DEGME). Health Canada will also continue its review, listing and prioritization for assessment of risk due to presence in the environment of substances in Food and Drugs Act regulated products.

HC and EC will continue to conduct research and monitoring programs to address existing and emerging chemicals of concern, and to inform risk assessment needs and risk management activities. Specific monitoring activities include completion of the second cycle of the Canadian Health Measures Survey and preparation for the release of the biomonitoring results in 2013-2014. Research in support of current CMP themes and priorities will continue and opportunities for synergies with government organizations and universities will be explored. Ways and means of improving knowledge transfer will also be implemented.

Work will continue on substances/products regulated under the Food and Drugs Act, including the development of Environmental Assessment Regulations and non-regulatory initiatives, re-evaluation of food additives and food packaging materials and assessment of food contaminants as indicated by CMP screening assessments and new scientific knowledge.

Work will also continue on the re-evaluation of previously approved pesticides according to legislated timelines and requirements under the Pest Control Products Act, as well as on continuing to monitor health and environmental incidents related to pesticides, analyzing trends and sales data, and taking regulatory action as needed.

EC will continue to develop compliance strategies and enforcement plans and will continue to deliver related activities, to promote regulatees' awareness and understanding of, and compliance, with regulatory requirements for CMP substances. Focus will be on delivering compliance promotion activities for the highest priority instruments as determined by the compliance priority setting process.

11. Federal Partner(s):

Health Canada (HC)

Federal Partner Program Spending ($ millions)

Federal Partner Program Activity (PA)	Names of Programs for Federal Partners	Total Allocation (from Start to End Date)	Planned Spending for 2012-13
*$9.3M ($3.1M/year) from 2012-2013 to 2014-2015 not included for the Banting Retrofit. Funds earmarked in fiscal framework and the department will seek access to these funds moving forward. Totals may differ within tables due to rounding of figures.
2.1 Health Products	a. Risk Management, Compliance Promotion and Enforcement	10.4	2.1
2.2 Food Safety and Nutrition	a. Risk Assessment	5.8	1.2
	b. Risk Management, Compliance Promotion and Enforcement	5.3	1.1
	c. Research	3.6	0.7
	d. Monitoring and Surveillance	5.4	1.1
	e. Stakeholder Engagement and Risk Communications	1.0	0.2
2.3 Environmental Risks to Health	a. Risk Assessment	57.5	11.5
	b. Risk Management, Compliance Promotion and Enforcement	72.7	14.5
	c. Research*	42.2	7.3
	d. Monitoring and Surveillance	43.3	8.7
	e. Stakeholder Engagement and Risk Communications	10.1	2.0
	f. Policy and Program Management	12.1	2.3
2.4 Consumer Products	a. Risk Assessment	12.8	2.6
	b. Risk Management, Compliance Promotion and Enforcement	12.9	2.6
2.7 Pesticide Safety	a. Risk Assessment	20.9	4.2
	b. Risk Management, Compliance Promotion and Enforcement	4.4	0.9
	c. Research	1.7	0.3
Internal Services		36.9	7.3
Total		359.2	70.6

Expected results by program:

• Threats to the health of Canadians posed by environmental risks are reduced
• Timely regulatory decisions for health products
• Increased awareness of the benefits and risks associated with the use of health products
• Timely regulatory system response to nutritional risks and food safety risks
• Increased awareness of Canadians on the benefits and risks related to food safety, nutrition and healthy eating
• Responsive regulatory system for consumer products
• Increased consumer/industry awareness of health risks and regulatory requirements related to consumer products
• Improved industry compliance with product safety obligations
• Timely regulatory decisions for pesticides
• Prevention of unacceptable risk from pesticides
• Mitigation or risks of/from non-compliance associated with pesticides

Environment Canada (EC)

Federal Partner Program Spending ($ millions)

Federal Partner Program Activity (PA)	Names of Programs for Federal Partners	Total Allocation (from Start to End Date)	Planned Spending for 2012-13
Totals may differ within tables due to rounding of figures.
3.1 Substances and Waste Management	a. Risk Assessment	17.4	3.5
	b. Risk Management	68.4	13.7
	c. Research	9.0	1.8
	d. Monitoring and Surveillance	24.6	4.9
3.3 Compliance Promotion and Enforcement - Pollution	a. Compliance Promotion	4.3	0.9
	b. Enforcement	11.3	2.3
Internal Services		12.4	2.5
Total		147.5	29.5

Expected results by program:

• Threats to Canadians and impacts on the environment posed by harmful substances and waste are reduced.
• Unlawful releases of harmful substances into the environment are prevented or minimized through enforcement and promotion of Environment Canada-administered laws and regulations.

Federal Partners - Total Program Spending ($ millions)

Total* Allocation For All Federal Partners (from Start to End Date):	Total Planned Spending for All Federal Partners for 2012-13:
*$9.3M ($3.1M/year) from 2012-2013 to 2014-2015 not included for the Banting Retrofit. Funds earmarked in fiscal framework and the department will seek access to these funds moving forward.
506.7	100.1

12. Results to be achieved by non-federal partners (if applicable): N/A

13. Contact information:

Suzanne Leppinen
Director
Chemicals Policy Bureau
Safe Environments Directorate
Healthy Environments and Consumer Safety Branch
Health Canada
Telephone: (613) 941-8071

Stewart Lindale
Director
Legislative and Regulatory Affairs
Environmental Stewardship Branch
Environment Canada
Telephone: (819) 934-2358

Early Childhood Development (ECD) Strategy for First Nations and Other Aboriginal Children

1. Name of Horizontal Initiative: Early Childhood Development (ECD) Strategy for First Nations and Other Aboriginal Children

2. Name of lead department(s): Health Canada (HC)

3. Lead department program activity: First Nations and Inuit Health Primary Health Care

4. Start date of the Horizontal Initiative:

• ECD component - October 2002
• Early Learning and Child Care (ELCC) component - December 2004

5. End date of the Horizontal Initiative:

• ECD component - ongoing
• ELCC component - ongoing

6. Total federal funding allocation (start to end date):

• ECD: $320 million 2002-03 to 2006-07 ($60 million in 2002-03 and $65 million thereafter). Ongoing: $65 million per year.
• ELCC: $45 million 2005-06 to 2007-08 ($14.5 million in 2005-06; $15.3 million in 2006-07; $15.2 million in 2007-08). Ongoing: $14 million per year.

7. Description of the Horizontal Initiative (including funding agreement): The goal of the Federal Strategy on Early Childhood Development for First Nations and Other Aboriginal Children, announced in October 2002, is to address the gap in life chances between Aboriginal and non-Aboriginal children. This initiative allocated $320 million over first five years which was shared by Health Canada, Human Resources and Skills Development Canada, Aboriginal Affairs and Northern Development Canada, and the Public Health Agency of Canada.

In December 2004, Cabinet approved an additional $45 million over three years (beginning fiscal year 2005-06) and $14 million ongoing for the ELCC component to improve integration and coordination of two ECD programs: Aboriginal Head Start On Reserve (AHSOR- Health Canada) and the First Nations and Inuit Child Care Initiative (FNICCI- Human Resources and Skills Development Canada).

8. Shared outcome(s): The ECD component complements the September 2000 First Ministers F/P/T ECD Agreement. It seeks to address the gap in life chances between Aboriginal and non-Aboriginal children by improving the developmental opportunities to which Aboriginal children (and their families) are exposed at an early age (0-6 years).

The ELCC component complements funding released to provinces and territories under the March 2003 Multilateral Framework for Early Learning and Childcare (ELCC) to improve access to ELCC programs and services.

9. Governance structure(s):

• Interdepartmental ECD ADM Steering Committee
• Interdepartmental ECD Working Group

10. Planning highlights: In collaboration with partners and stakeholders, federal departments will continue to build on evidence to inform programming and capacity building efforts, and to enhance linkages and integrate services to better support Aboriginal children and families.

11. Federal Partner(s):

Health Canada (HC)

Federal Partner Program Spending ($ millions)

Federal Partner Program Activity (PA)	Names of Programs for Federal Partners	Total Allocation (from Start to End Date)	Planned Spending for 2012-13
*The budget for the AHSOR program in 2009-2010 was $59 million which included $25 million historical funding, $21.5 million in enhanced funding under the Early Childhood Development (ECD) Federal Strategy, $7.5 million in Early Learning and Child Care (ELCC) funds and $5 million under upstream investments.
First Nations and Inuit Health	Aboriginal Head Start on Reserve (AHSOR)	107.595 (2002-03 through to 2006-07; 21.519/year). 21.519/year ongoing.* Committed in 2002.	21.519
		ELCC 24.0 (2005-06 through to 2007-08, 7.5 in 2005-06, 8.3 in 2006-07; 8.2 in 2007-08). 7.5 in 2008-09 and ongoing. Committed in 2005.	7.5
	Fetal Alcohol Spectrum Disorder - First Nations and Inuit Component (FASD-FNIC)	70.0 (2002-03 through to 2006-07; 10.0 in 2002-03 and 15.0 thereafter). 15.0/ year ongoing. Committed in 2002.	15.0
	Capacity Building	5.075 (2002-03 through to 2006-07; 1.015/year). 1.015/ year ongoing. Committed in 2002.	1.015
Total		From start to 2009-10 ECD: 295.272 ELCC: 39.0	ECD: 37.534 ELCC: 7.5

Electronic Link: For more information, please visit Aboriginal Head Start on Reserve and Fetal Alchohol Syndrom/Fetal Alcohol Effects. 

Expected results by program:

Aboriginal Head Start on Reserve (ADSOR):

• Ongoing program support and enhancement
• Increase integration, coordination, access, and quality of programming (i.e. identify core competencies of workers/staff)

Fetal Alcohol Spectrum Disorder - First Nations and Inuit Component (FASD-FNIC):

• Program enhancement, i.e. develop strategies on how to implement the considerations put forward in both the FASD Community Coordinator Pilot Project Special Study and the FASD Mentoring Special Study with the goal of enhancing linkages and integrating services to support First Nations and Inuit women with addictions.

Capacity Building:

• Increase capacity of National Aboriginal Organizations
• Enhance capacity of community Early Childhood Education practitioners

Public Health Agency of Canada (PHAC)

Federal Partner Program Spending ($ millions)

Federal Partner Program Activity (PA)	Names of Programs for Federal Partners	Total Allocation (from Start to End Date)	Planned Spending for 2012-13
Health Promotion	Aboriginal Head Start in Urban and Northern Communities (AHSUNC)	62.880 (2002-03 through to 2006-07; 12.576/ year and ongoing.	12.576
		5.0/year as per renewal of AHSUNC (2010-11). Committed in 2002.	5.0
	Capacity Building	2.5 (2002-03 through to 2006-07; 0.5/year) and ongoing. Committed in 2002.	0.5
Total		109.608	18.076

Electronic Link: For more information, visit Aboriginal Head Start in Urban and Northern Communities (AHSUNC)

Aboriginal Affairs and Northern Development Canada (AANDC)

Federal Partner Program Spending ($ millions)

Federal Partner Program Activity (PA)	Names of Programs for Federal Partners	Total Allocation (from Start to End Date)	Planned Spending for 2012-13
The People - Social Development	Capacity building	5.05 (total for 2001-03 through to 2006-07; 1.01/year and ongoing) Committed in 2002.	1.01
Total		9.01	1.01

Expected results by program: Support horizontal work with ECD partners by funding research and capacity-building.

Federal Partners - Total Program Spending ($ millions)

Total Allocation For All Federal Partners (from Start to End Date)	Total Planned Spending for All Federal Partners for 2012-13
ECD: $320 million 2002-03 to 2006-07 ($60 million in 2002-03 and $65 million thereafter). Ongoing: $65 million per year.	ECD: 55.651
ELCC: $45 million 2005-06 to 2007-08 ($14.5 million in 2005-06; $15.3 million in 2006-07; $15.2 million in 2007-08). Ongoing: $14 million per year.	ELCC: 7.5
Total	63.151

12. Results to be achieved by non-federal partners (if applicable): N/A

13. Contact Information:

Cathy Winters
Senior Policy Coordinator
Children and Youth Division
Community Programs Directorate
First Nations and Inuit Health Branch
Tunney's Pasture, Ottawa, ON K1A 0K9
Telephone: (613) 946-2896

Food and Consumer Safety Action Plan (FCSAP)

1. Name of Horizontal Initiative: Food and Consumer Safety Action Plan (FCSAP)

2. Name of lead department(s): The lead is shared between Health Canada (HC), the Canadian Food Inspection Agency (CFIA), the Public Health Agency of Canada (PHAC), and the Canadian Institutes of Health Research (CIHR).

3. Lead department program:

• HC: Health Products, Consumer Products Safety, Pesticide Safety and Food Safety and Nutrition;
• CFIA: Food Safety Program;
• PHAC: Health Promotion, Chronic Disease Prevention and Control, and Infectious Disease Prevention and Control;
• CIHR: Health and Health Services Advances.

4. Start date of the Horizontal Initiative: Fiscal Year 2008-2009.

5. End date of the Horizontal Initiative: Fiscal Year 2012-2013 (and ongoing).

6. Total federal funding allocation (start to end date): $489.4 million over five years ending in Fiscal Year 2012-2013 (and $126.7 million ongoing).

7. Description of the Horizontal Initiative (including funding agreement): The federal government is responsible for promoting the health and safety of Canadians. A key part of this role is ensuring that the food, health and consumer products used by Canadians are safe. Adverse consequences associated with unsafe products impact not only the Canadian public, but also the Canadian economy. The FCSAP is a horizontal initiative aimed at modernizing and strengthening Canada's safety system for food, health and consumer products. A number of high-profile incidents, such as lead and ingestible magnets in children's toys, food borne illness outbreaks, and the global withdrawal of some prescription medicines, have underscored the need for government action.

The FCSAP includes efforts to modernize Canada's regulatory system to enable it to better protect Canadians from unsafe consumer products in the face of current realities and future pressures. The FCSAP bolsters Canada's regulatory system by committing to amending or replacing outdated health and safety legislation with new legislative regimes that respond to modern realities, and by enhancing safety programs in areas where modern legislative tools already exist. The FCSAP helps to ensure that Canadians have the information they need to assess the risks and benefits associated with the consumer and health products they choose to use, and to minimize risks associated with food safety.

The FCSAP is an integrated, risk-based plan and includes a series of initiatives that are premised on three key areas of action: active prevention, targeted oversight and rapid response. We focus on active prevention to avoid as many incidents as possible and work closely with industry to promote awareness, provide regulatory guidance, and help identify safety concerns at an early stage. Targeted oversight provides for early detection of safety problems and further safety verification at the appropriate stage in a product's life cycle. To improve rapid response capabilities and ensure the government has the ability to act quickly and effectively when needed, we work to enhance health and safety risk assessments, strengthen recall capacity, and increase the efficiency in responding and communicating clearly with consumers and stakeholders.

8. Shared outcome(s):

• Increased knowledge of food risks and product safety (scientific and surveillance/monitoring);
• Increased industry awareness and understanding of regulatory requirements;
• Increased industry compliance with safety standards;
• Increased consumer awareness and understanding of safety risks associated with health and consumer products and food;
• Strengthened oversight and response to safety incidents;
• Increased consumer confidence in health and consumer products and food;
• Increased trade-partner confidence in Canadian controls, which meet international standards;
• Increased availability of safe and effective products; and
• Level playing field where imports can be demonstrated to meet Canadian requirements.

9. Governance structure(s): The Minister of Health and the Minister of Agriculture and Agri-Food Canada have joint responsibility and accountability for results, and for providing information on progress achieved by the FCSAP.

A Governance Framework has been established and endorsed by all of the partner departments/agencies. To facilitate horizontal coordination, the following Director General (DG)/Executive Director (ED) level Task Forces have been established:

• Legislative and Regulatory Task Force;
• Health Products Task Force;
• Consumer Products Task Force;
• Food Task Force; and the
• Communications Task Force.

These Task Forces report to a DG/ED level Coordinating Committee. An Assistant Deputy Minister (ADM)/Vice President (VP) level Steering Committee provides direction to the Coordinating Committee. An Oversight Committee of Deputy Heads facilitates the provision of high level guidance to the Steering Committee.

Health Canada's Health Products and Food Branch (HPFB) has primary responsibility for implementing FCSAP activities related to health products with support from Health Canada's Strategic Policy Branch (SPB) and the Canadian Institutes of Health Research (CIHR) on one initiative (increased knowledge of post-market drug safety and effectiveness).

Health Canada's Healthy Environments and Consumer Safety Branch (HECSB) and the Pest Management Regulatory Agency (PMRA), along with the Public Health Agency of Canada (PHAC), work together to implement FCSAP activities related to consumer products.

The Canadian Food Inspection Agency (CFIA), Health Canada's Health Products and Food Branch (HPFB) and the Public Health Agency of Canada (PHAC) work together to implement FCSAP activities related to food.

The Public Affairs, Consultation and Communications Branch (PACCB) of Health Canada provides communications support for all of the above activities and will coordinate or lead many of the horizontal Departmental activities under the Consumer Information Strategy.

10. Planning Highlights: The FCSAP reflects the need to modernize and sharpen the focus of Government action to protect Canadians and responds to the economic realities and new technologies of the 21st century, such as globalization and the introduction of more complex products. The FCSAP is an integrated, risk-based plan with the streams of initiatives (premised on the three key areas of action) aligned to meet these needs.

11. Federal Partner(s):

Health Canada (HC)

Federal Partner Program Spending ($ millions)

Federal Partner Program Activity (PA)	Names of Programs for Federal Partners	Total Allocation (from Start to End Date)	Planned Spending for 2012-13
Health Products	Active Prevention	57.6	11.7
	Targeted Oversight	34.6	10.2
	Rapid Response	Existing resources	Existing resources
Consumer Products Safety	Active Prevention	41.0	13.7
	Targeted Oversight	15.7	4.9
	Rapid Response	17.9	4.4
Pesticide Safety	Active Prevention	6.9	1.6
	Rapid Response	8.0	2.1
Food Safety and Nutrition	Active Prevention	29.6	7.6
	Rapid Response	1.3	0.3
Total		212.6	56.5

Expected results by program (HC):

Active Prevention

Regulatory modernization is an area of great importance for Health Canada. In 2012-13, the Health Products program will continue to engage stakeholders in discussions to support the policy development process for modernized regulatory frameworks.

In an effort to improve the safety, quality and efficacy of health products, the Health Products program will initiate regulatory change to include regulatory oversight of the manufacturing of active pharmaceutical ingredients. The Active Pharmaceutical Ingredient (API) Inspection Program is dependent on the new API legislation, therefore, API inspections are not possible at this time and targets cannot be set until the regulatory amendments come into force. Planning and implementation work on inspection training, compliance and promotion, as well as on quality system documents continue while these regulations are pending.

As part of its review of drugs and medical devices, Health Canada prepares Summary Basis of Decision (SBD) documents to explain why certain products are authorized for sale in Canada. The documents include regulatory, safety, effectiveness and quality (chemistry and manufacturing) considerations.

Health Canada also produces Product Monographs (PM) that are factual, scientific documents on a drug product that describes the properties, claims, indications and conditions as well as information that may be required for the optimal, safe and effective use of the drug. The Product Monograph consists of three sections: Part 1 - Health Professional Information, i.e., prescribing information; Part 2 - Scientific Information; and Part 3 - Consumer Information. Health Canada will be finalising the plain language labelling improvements to PM Part III.

As part of the lifecycle approach, and in the absence of enabling legislation, Health Canada will continue reviewing Risk Management Plans (RMP) for therapeutic products. Generally, these plans are reviewed as part of a New Drug Submission and for various therapeutic health products in the post market setting. An RMP can be requested by Health Canada or submitted voluntarily by the manufacturer. It provides information related to identified and potential risks, strategies to characterize the risks in question, and a risk minimization plan. 

To increase awareness and compliance with regulatory requirements, Health Canada will continue to engage in pre-submission meetings with industry. These meetings provide the opportunity to better document, track, monitor and evaluate the exchange of information as well as obtain feedback regarding areas of concern prior to filing a submission. 

As technology adapts and Canadians look for their information in different ways -- via websites, smart phones, TV, and print materials - Health Canada continues to strive to offer information in a variety of new and traditional ways. In 2012-13, PACCB will continue to focus on improving the structure and content of our websites. We will launch a new Recalls and Safety Alerts Database making it easier for Canadians to find important safety information.

Expected Results: Increase industry awareness and knowledge of regulatory requirements; Enhance knowledge of post-market health products safety risks to inform decisions; increase oversight of the risk management and risk mitigation strategies for health products; increase safety of APIs through industry compliance with the Food and Drug Act (FDA) and its regulations; improve timeliness of pre-market reviews; increase awareness and understanding of the safe use of health products by consumers and health care professionals.

Performance Indicator: number of engagement opportunities with industry, international collaborations; number of guidance/educational tools developed; number of standards, frameworks and policies developed or modified; and number of consultations/ engagement activities with Canadians and target populations; improved timeliness of pre-market reviews; number risk management and mitigation plans received, reviewed and implemented; percent of API firms inspected.

Targeted Oversight

Through the National Border Integrity Program, Health Canada's ability to make and support admissibility decisions at the border as they relate to health products will be strengthened. This program was implemented in 2008 and is delivered by Health Canada. The program will continue to advance its ability to monitor and control the importation of health products by addressing challenges involved in reducing the health and safety risk for products entering Canada through the following initiatives: a national standardized process for the handling of health products at the border; establishment of service standards between Canada Border Services Agency (CBSA) and Health Canada to improve the ability to respond when safety incidents occur; and, undertaking public education activities to inform Canadians of risk associated with the importation of non-compliant health products. An interim compliance policy to address key border issues is intended to be implemented in fiscal year 2012-13. Meanwhile, Health Canada will continue to work to address these issues on a more permanent basis.

In addition, Health Canada will continue to enhance the post-market surveillance elements of the program through increased efforts focused on review of Periodic Safety Update Reports (PSURs) - documents that summarize the worldwide safety experience of a health product at pre-established post-authorization times. Furthermore, Health Canada will continue to seek opportunities to expand and enhance the Post Market Reporting Compliance (PMRC) inspection program, such as through a review of international best practices and the incorporation of additional elements to its inspections.

The Department will continue to work with its partners to increase reporting of adverse drug reactions through the Hospital-Based Mandatory Reporting Project for Adverse Drug Reactions. Implementation of mandatory reporting is however dependent upon the passing of relevant enabling legislation. Health Canada also promotes adverse reaction reporting through the Canada Vigilance Regional Offices, by way of outreach and promotional activities, as a way to increase health professional and consumer awareness of, and participation in, the Canada Vigilance Program. 

In partnership with the Canadian Institutes of Health Research (CIHR), Health Canada has implemented the Drug Safety and Effectiveness Network (DSEN), a pan-Canadian network of centres of excellence in post-market pharmaceutical research, to fund studies that will inform pharmaceutical decision-making across the health care system. The DSEN partners (CIHR and Health Canada) will continue to work collaboratively to refine the processes and procedures to support DSEN research, including the development of a framework to prioritize DSEN research queries to reflect pan-Canadian needs for evidence on past market safety and effectiveness. 

Expected Results: Enhance capacity of Health Canada and industry to identify and respond to risk issues; increase capacity to identify safety issues with health products on the market; increase knowledge of post-market drug safety and effectiveness to inform decisions and increase capacity to address priority research on post-market drug safety and effectiveness; improve ability to monitor and control importation of health products.

Performance Indicators: Year over year increase in PSUR submitted by industry; number new safety signals generated through PSUR reviews per year; percent of safety issues identified by Market Authorization Holders (MAH) resulting in product monograph changes or regulatory action to mitigate risk; percent of ARs addressed within service standards; number of import alerts resulting in detecting/stopping non-compliant products at the border.

Active Prevention

The Consumer Products Safety program will provide information to consumers and work closely with industry to promote awareness, provide regulatory guidance, help identify and systematically assess safety risks at early and ongoing stages of product development, develop standards and share best practices.

Targeted Oversight

Through targeted oversight actions, the Consumer Product Safety program works to detect safety problems as early as possible and at all stages in a product's life cycle. Under the new Canada Consumer Product Safety Act, Consumer Products Safety program has improved authorities to ensure investigative actions are being taken to determine the safety profile of products and to verify that preventative measures are being implemented.

Expected Results: Improved information and reporting of consumer product safety related incidents (by industry and consumers).

Rapid Response

The Government is equipped to respond rapidly to remove unsafe consumer products from shelves, preventing them from reaching consumers. While the Department continues to operate with a step-wise approach to compliance and enforcement by working with industry to voluntarily take corrective actions, the Canada Consumer Product Safety Act (CCPSA) offers new measures to protect Canadians from unsafe consumer products. This includes a general prohibition against products that pose an unreasonable danger, the authority to order industry to recall* and/or take other corrective measures and in the case of industry's failure to act in a timely manner, Health Canada's ability to initiate a recall and/or corrective measures to ensure the health and safety of Canadians.

*Recall is a process by which the responsible establishment in Canada notifies consumers of the danger associated with a product and this notice should be accompanied by all of the following steps:

• Stopping distribution of product by upper levels of trade;
• Stopping sale of product by lower levels of trade;
• Determining accounts/producing distribution lists and gathering necessary information pertaining to the recall;
• Notifying accounts of the recall, with instructions to take specified measures (correct, return product/accept returns of products, disposal);
• Removing product throughout supply chain; and,
• Completing recall effectiveness form(s) and reporting on any reconciled product from accounts.

(The recall may also include other corrective measures in a separate order.)

Expected results: Increased consumer/industry awareness of health risks and regulatory requirements related to consumer products; Improved industry compliance** with product safety obligations.

**Compliance is measured by a monitoring approach. Compliance results are determined by monitoring activities following initial inspection. Due to the non-license (post-market) nature of the consumer products industry, compliance verification is limited to primary level establishments and targeted to the highest levels of trade.

Pest Management Regulatory Agency (PMRA) encourages and facilitates industry development and adoption of quality assurance and stewardship programs for the safe manufacture and subsequent selection and use of pesticides and other consumer products containing pesticides. Retailers of pest control products often rely on their distributors for validation of access to products with lapsed registrations, or which have never been registered. Work under this strategy fosters an increased knowledge of the requirements of the Pest Controls Products Act (PCPA) and an awareness of the tools available to validate the status of the pest control products and their label information.

PMRA enhances compliance targeting and enforcement capacity in support of expanded regulatory authority under the PCPA, and maintains public confidence in pesticide product safety. In conjunction with other federal and provincial regulators, Health Canada continues the development and implementation of an evidence and risk-based approach to identify and act on situations of higher risk associated with non-compliance. Activities continue to include the enhancement of current information/intelligence networks, analysis and an updated targeting strategy to verify the presence of compliance and the reasons that non-compliance was found to exist. Activities also include an updated strategy to address the importation of unregistered consumer pesticides where the safety would be unknown.

The PMRA also provides information to consumers through outreach programs, these initiatives are critical in promoting the safe and proper use of pesticides and ensuring risk reduction practices are established along the entire supply chain. The compliance strategies under active prevention aim to engage stakeholders in order to test assumptions about the ability and will to comply in a timely and effective manner with enforcement actions.

Expected results: Increased awareness and understanding of product safety obligations, standards and regulatory requirements by industry; improved risk-based monitoring of products.

Active Prevention

The Food Safety and Nutrition program will continue to support the Government as it develops and seeks Parliamentary approval for amendments to food safety legislation.

Health Canada will continue to enhance risk management measures for priority food safety hazards in foods, implement Food Allergy Incident Prevention Measures, consult with industry and stakeholders on key files, and engage with international standards bodies while developing standards, policies, regulations and processes.

Expected Results: Increased effective assessment and mitigation strategies of food safety risks.

Performance Indicators: number of risk modelling activities conducted, number and type of involvement in International initiatives that support industry, number and type of involvement with international standard setting initiatives, percent and range of new submissions addressed within time standards, research in policy and RIAS, as well as the considerations of consumer and stakeholder feedback documented in decision-making.

Targeted Oversight

The Food Safety & Nutrition program has no targeted oversight funding under this stream.

Rapid Response

Under the rapid response pillar the Food Safety and Nutrition program will continue its participation in the Partnership for Consumer Food Safety Education with the goal of promoting the "Be Food Safe" campaign and will continue to develop new education materials for consumers to promote food safety in an effort to reduce foodborne disease outbreaks in Canada.

Expected Results: Consumers make informed decisions about food.

Performance Indicators: percent of consumers aware and knowledgeable of their role in food safety, and how this is used in decision-making.

Canadian Food Inspection Agency (CFIA)

Federal Partner Program Spending ($ millions)

Federal Partner Program Activity (PA)	Names of Programs for Federal Partners	Total Allocation (from Start to End Date)	Planned Spending for 2012-13
Food Safety Program and Internal Services	Active Prevention	114.2	27.3
	Targeted Oversight	77.0	21.9
	Rapid Response	32.2	7.2
Total		223.4	56.4

Expected results by program (CFIA):

Active Prevention

The Canadian Food Inspection Agency's (CFIA) food safety initiatives aimed at ensuring active prevention include measures to enable government to better understand and identify food safety risks and to work with industry to implement effective food safety risk mitigation strategies. The CFIA, along with its federal partners, will strive to strengthen food safety standards and regulations and will engage Canadians in making decisions with respect to food safety.

In 2012-13, the CFIA will continue to support the Government as it develops and seeks Parliamentary approval for amendments to food safety legislation, and will move forward with its Imported Food Sector Product Regulations regulatory proposal under the Canada Agricultural Products Act.

The CFIA will continue to work with Health Canada on data collection and risk mapping towards identification and characterization of areas of concern, including imported food ingredients, produce, mycotoxins in cereals and undeclared allergens. Risk mapping will identify gaps in standard-setting and policy development and will assist in focusing operational efforts on areas of greatest risk. Data collected through baseline surveillance will serve to fill information gaps.

The CFIA will continue engagement with counterparts in foreign countries to enhance food safety information exchange and identify best practices to inform risk management approaches.

The CFIA will continue to revise its food safety programming for verification of industry food safety systems in high-risk sectors and IM/IT business solutions for supporting importer licensing will be further developed. As well, the CFIA will also continue to inform consumers and industry on the Canadian Food Labelling Initiative and the use of Product of Canada and Made in Canada claims on food products.

Expected results: To better identify, assess, and prioritize potential food safety hazards through risk mapping, information gathering, and sampling and testing of foods on the Canadian marketplace and to inform the relevant Agency stakeholders on relative risk in order to influence decisions and priorities for different food/hazard combinations; improved industry compliance; industry implementation of preventive food safety systems; establishment of standards, regulations, and policies that contribute to the prevention of food safety issues through the product lifecycle.

Performance indicators: number of planned and percent completed commodity / hazard targeted surveys to address information gaps; number of risk profiles completed; percent completion of re-engineered risk prioritization, profiling, and mapping approaches; number of consultations held with industry and other jurisdictions; percent completion of revised approaches to food safety system verification; number of inquiries related to Product of Canada guidelines; percent completion of the supporting IM/IT infrastructure and tool for importer licensing management

Targeted Oversight

In 2012-13, the CFIA will continue to adapt its food safety inspection practices for high-risk sectors. Evaluation and verification of industry's food safety control systems in both fresh fruit and vegetable and non-federally registered sectors will take place with a focus on imported products. Method development and testing in targeted areas will continue, and front-line capacity will continue to increase. Border blitz will be conducted, and IM/IT business solutions for supporting enhanced tracking of imported food products will be further developed.

Expected results: Improved industry compliance with food safety standards; modern tools and new risk-based approaches contribute to improved safety of imported foods.

Performance indicators: number and percent of planned high-risk food safety inspections and verifications completed; number of border blitzes conducted; percent completion of the supporting IM/IT infrastructure and enhancements to tools for import tracking; number required and percent in place of new hires to support increased import tracking and enhanced inspection / verification activities; number and percent of new testing methodologies developed and implemented.

Rapid Response

Towards ensuring rapid response to food safety issues and emergencies, enhanced recall capacity will enable the Government of Canada to effectively respond to and conduct investigations for an anticipated increased number of food recalls resulting from targeted oversight activities. Targeted consumer risk communication activities and products will also improve Canadian's awareness of food safety issues and recalls and will help consumers better protect their health.

In 2012-13, the CFIA will continue to augment human resource capacity to address identified food safety issues. Enhancements to food safety recall and investigation methodology will continue.

Expected results: Timely and efficient recall capacity in the face of increased identification of potential risks through targeted testing and other information; better public understanding of food safety risks; increased consumer use of various food safety alert systems; and increased public trust and confidence in the food safety system.

Performance indicators: number of personnel trained and available to support recall activities; number of recalls and percent conducted in accordance with CFIA standards; number of and percent of required investigations conducted in accordance with CFIA standards; number of communications initiatives aimed at increasing consumer awareness of food safety issues and recall; percent of consumers aware of food safety issues.

Public Health Agency of Canada (PHAC)

Federal Partner Program Spending ($ millions)

Federal Partner Program Activity (PA)	Names of Programs for Federal Partners	Total Allocation (from Start to End Date)	Planned Spending for 2012-13
Surveillance and Population Health Assessment	Targeted Oversight	22.8	5.3
Disease and Injury Prevention and Mitigation	Targeted Oversight	3.5	1.00534
Total		26.3	6.30534

Expected results by program (PHAC):

Targeted Oversight

Through ongoing and expanded data collection, analysis and reporting on the rates, patterns and circumstances of unintentional injury of Canadians, focusing on children and seniors, PHAC will contribute to the evidence base for policies, practices and programs for injury prevention and control.

Expected results: 1) More and better data on accidents, injuries, illnesses and deaths due to consumer products. 2) Engagement of risk assessment stakeholders.

Canadian Institutes of Health Research (CIHR)

Federal Partner Program Spending ($ millions)

Federal Partner Program Activity (PA)	Names of Programs for Federal Partners	Total Allocation (from Start to End Date)	Planned Spending for 2012-13
Health and Health Services Advances	Targeted Oversight	27.1	9.0
Total		27.1	9.0

Expected results by program (CIHR):

Targeted Oversight

The Canadian Institutes of Health Research will make investments and focus efforts in advancing the Drug Safety and Effectiveness Network to increase the available evidence on drug safety and effectiveness to regulators, policy-makers, health care providers and patients and to increase capacity within Canada to undertake high-quality post-market research in this area.

Work will continue on engaging interested parties during the development of the Network, delivering on peer reviewed funding opportunities for the initiative and responding to strategic direction received from the DSEN Steering Committee.

Expected results: Increased knowledge of post-market drug safety and effectiveness to inform decisions and increased capacity in Canada to address priority research on post-market drug safety and effectiveness.

Performance Indicators: Evidence of the dissemination of research knowledge to the target audience.

Federal Partners - Total Program Spending ($ millions)

Total* Allocation For All Federal Partners (from Start to End Date):	Total Planned Spending for All Federal Partners for 2012-13:
Health Canada	56.5
Canadian Food and Inspection Agency	56.4
Public Health Agency of Canada	6.30534
Canadian Institutes of Health Research	9.0
Total	128.20534

12. Results to be achieved by non-federal partners (if applicable): N/A

13. Contact information: N/A